CAPTRUST Financial Advisors
TEVA icon

CAPTRUST Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
56,656
+6,861
+14% +$229K ﹤0.01% 1330
2026
Q1 		$1.5M Buy
49,795
+35,080
+238% +$1.13M ﹤0.01% 1362
2025
Q4 		$459K Buy
14,715
+302
+2% +$7.44K ﹤0.01% 1952
2025
Q3 		$291K Sell
14,413
-1,325
-8% -$23.3K ﹤0.01% 2188
2025
Q2 		$264K Sell
15,738
-998
-6% -$16.1K ﹤0.01% 2132
2025
Q1 		$257K Buy
16,736
+8,457
+102% +$151K ﹤0.01% 2025
2024
Q4 		$182K Sell
8,279
-7,507
-48% -$137K ﹤0.01% 2153
2024
Q3 		$284K Buy
15,786
+5,146
+48% +$90.1K ﹤0.01% 1907
2024
Q2 		$173K Buy
+10,640
New +$164K ﹤0.01% 2068
2024
Q1 		– Sell
-13,171
Closed -$138K – 2622
2023
Q4 		$138K Buy
13,171
+387
+3% +$3.61K ﹤0.01% 2481
2023
Q3 		$130K Buy
+12,784
New +$119K ﹤0.01% 2397
2022
Q3 		– Sell
-2,727
Closed -$21K – 3848
2022
Q2 		$21K Sell
2,727
-2,461
-47% -$21.4K ﹤0.01% 3351
2022
Q1 		$49K Sell
5,188
-1,289
-20% -$10.8K ﹤0.01% 2794
2021
Q4 		$52K Buy
6,477
+4,995
+337% +$45.1K ﹤0.01% 2638
2021
Q3 		$14K Hold
1,482
– – ﹤0.01% 3411
2021
Q2 		$15K Hold
1,482
– – ﹤0.01% 3319
2021
Q1 		$17K Sell
1,482
-357
-19% -$4.09K ﹤0.01% 3120
2020
Q4 		$18K Buy
1,839
+709
+63% +$6.79K ﹤0.01% 2303
2020
Q3 		$10K Buy
1,130
+589
+109% +$6.23K ﹤0.01% 2287
2020
Q2 		$6K Buy
+541
New +$6.12K ﹤0.01% 2360

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

CAPTRUST Financial Advisors's TEVA Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Teva Pharmaceuticals (TEVA) stake by 14% in Q2 2026, buying an estimated $229K and bringing the position to 56,656 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1330.

CAPTRUST Financial Advisors first reported a position in TEVA in Q2 2020 and has held it in 20 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • CAPTRUST Financial Advisors held 56,656 shares of Teva Pharmaceuticals worth $1.92M as of Q2 2026.
  • CAPTRUST Financial Advisors bought 6,861 Teva Pharmaceuticals shares in Q2 2026, an estimated $229K.
  • Teva Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1330 holding.
  • CAPTRUST Financial Advisors first reported a position in Teva Pharmaceuticals in Q2 2020 and has held it in 20 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.